Jeffrey Cary
Pulmonary Disease · Seattle, WANPI 1235129131
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $66,750 of the $105,625 with a category attached, or 63.2%. 7 manufacturers reported payments, led by Mylan Specialty L.p. at 47.6% of the total. Reporting peaked in 2019 at $46,082 and has fallen 95.3% since, to $2,178 in 2025. Among pulmonary disease clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 172 payments — averaging $614.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mylan Specialty L.p.$50K
- Sunovion Pharmaceuticals Inc.$35K
- Genentech USA, Inc.$17K
- Viatris Specialty LLC$2K
- Boston Scientific$166
- GSK$53
- plus $50 from 1 others
Across 6 payments — averaging $5274.17 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Genentech, Inc.$24K
- Novartis$7K
What the payments were for
- Consulting fees$16,83016%
- Speaking & faculty fees$66,75063%
- Travel & lodging$18,54218%
- Food & beverage$3,4533%
- Education$500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mylan Specialty L.p. | 92 | $50,310 |
| Sunovion Pharmaceuticals Inc. | 56 | $35,418 |
| Genentech USA, Inc. | 17 | $17,451 |
| Viatris Specialty LLC | 3 | $2,178 |
| Boston Scientific | 2 | $166 |
| GSK | 1 | $53 |
| Genentech, Inc. | 1 | $50 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Yupelri$51,160
- LONHALA MAGNAIR$34,005
- Esbriet$17,111
- GENERAL PULMONARY$143
How this compares
$105,625 in reported general payments places this provider in the 95th percentile of 275 pulmonary disease providers in Washington.
Other pulmonary disease in Seattle
- Jed GordenSeattle$236K
- Oneil BainsSeattle$156K
- Ganesh RaghuSeattle$147K
- Amy DickeySeattle$71K
- Lawrence HoSeattle$70K
- Christopher GossSeattle$44K
- Reena MehraSeattle$36K
- Rebecca SellSeattle$30K
- Peter LearySeattle$27K
- Mark WurfelSeattle$24K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.